Medable named #1 Leader in DCT for second year

For the second consecutive year, Medable has been named Leader decentralized clinical trial products per the Everest Group’s PEAK Matrix® assessment, which evaluates DCT products from 24 companies based on vision, capability and market impact. Medable ranked highest in the Leaders quadrant with top scores for both vision and capability as well as market impact.

Everest Group’s PEAK Matrix® is the most trusted, fact-based analysis of global service providers, locations, products, and solutions.

Heading

Heading

Heading

Save the Date!
This is some text inside of a div block.
This is some text inside of a div block.
This is some text inside of a div block.
Download the report